Drug Induced Liver Toxicity 1st Edition by Minjun Chen, Yvonne Will ISBN 1493992562 978-1493992560

Drug Induced Liver Toxicity 1st Edition by Minjun Chen, Yvonne Will- Ebook PDF Instant Download/Delivery: 1493992562, 978-1493992560

Full download Drug Induced Liver Toxicity 1st Edition  after payment

Product details:

ISBN 10: 1493992562 

ISBN 13: 978-1493992560

Author:  Minjun Chen, Yvonne Will

 This book provides a comprehensive view of the methodologies used for the study of liver toxicity encountered throughout the whole life cycle of a drug, from drug discovery, to clinical trial, post-marketing, and even clinical practice. Organized into six sections, the first section introduces the mechanisms contributing to drug-induced liver toxicity. The second and third section explore in silico and in vitro approaches used to help mitigate hepatotoxicity liability at the early stages of drug development. The fourth section describes methodologies applied in regulatory processes, including preclinical studies, clinical trials, and post-marketing surveillance. The fifth section discusses clinical hepatotoxicity. Emerging technologies are examined in the final section. As a volume in the Methods in Pharmacology and Toxicology series, chapters include the kind of expert advice that will lead to optimal results.
Authoritative and practical, Drug-InducedLiver Toxicity serves all those who aim to improve assessment and understanding of hepatotoxic potentials of new medications and marketed drugs.

Table of contents: 

1. Overview of Mechanisms of Drug-Induced Liver Injury (DILI) and Key Challenges in DILI Research

2. Detection, Elimination, Mitigation, and Prediction of Drug-Induced Liver Injury in Drug Discovery

3. Drug-Induced Liver Injury (DILI) Classification and Its Application on Human DILI Risk Prediction

4. Physicochemical Properties and Structural Alerts

5. Quantitative Structure–Activity Relationship Models for Predicting Risk of Drug-Induced Liver Injury in Humans

6. An Introduction to DILIsym® Software, a Mechanistic Mathematical Representation of Drug-Induced Liver Injury

7. Prediction of Human Liver Toxicity Using In Vitro Assays: Limitations and Opportunities

8. Use of Liver-Derived Cell Lines for the Study of Drug-Induced Liver Injury

9. Evaluation of Drug-Induced Liver Injuries (DILI) with Human Hepatocytes: Scientific Rationale and Experimental Approaches

10. Status and Use of Induced Pluripotent Stem Cells (iPSCs) in Toxicity Testing

11. Engineered Human Liver Cocultures for Investigating Drug-Induced Liver Injury

12. Status and Future of 3D Cell Culture in Toxicity Testing

13. Reactive Metabolite Assessment in Drug Discovery and Development in Support of Safe Drug Design

14. In Vitro Assessment of Mitochondrial Toxicity to Predict Drug-Induced Liver Injury

15. Bile Salt Export Pump: Drug-Induced Liver Injury and Assessment Approaches

16. High Content Screening for Prediction of Human Drug-Induced Liver Injury

17. Interpretation, Integration, and Implementation of In Vitro Assay Data: The Predictive Toxicity Challenge

18. Perspectives on the Regulatory and Clinical Science of Drug-Induced Liver Injury (DILI)

19. Regulatory Toxicological Studies: Identifying Drug-Induced Liver Injury Using Nonclinical Studies

20. Hy’s Law and eDISH for Clinical Studies

21. Variability in Baseline Liver Test Values in Clinical Trials: Challenges in Enhancing Drug-Induced Liver Injury Assessment in Subjects with Liver Disease

22. Postmarketing Surveillance of Drug-Induced Liver Injury

23. Host Risk Modifiers in Idiosyncratic Drug-Induced Liver Injury (DILI) and Its Interplay with Drug Properties

24. Human Leukocyte Antigen (HLA) and Other Genetic Risk Factors in Drug-Induced Liver Injury (DILI)

25. Immune Mechanisms in Drug-Induced Liver Injury

26. Translational and Mechanistic Biomarkers of Drug-Induced Liver Injury – Candidates and Qualification Strategies

27. Causality Assessment Methods in Drug-Induced Liver Injury

28. Circulating MicroRNAs as Novel Biomarkers of Drug-Induced Liver Injury in Humans

29. Systems Microscopy Approaches in Unraveling and Predicting Drug-Induced Liver Injury (DILI)

30. Noninvasive Preclinical and Clinical Imaging of Liver Transporter Function Relevant to Drug-Induced Liver Injury

31. Correction to: Regulatory Toxicological Studies: Identifying Drug-Induced Liver Injury Using Nonclinical Studies

People also search for:

 drug induced liver toxicity symptoms
    
drug induced liver toxicity icd 10
    
acetaminophen toxicity drug induced liver injury
    
drug induced liver disease acetaminophen toxicity
    
liver toxicity from medication

Tags: Minjun Chen, Yvonne Will, Drug Induced, Liver Toxicity